- Report
- April 2023
- 80 Pages
Germany
From €4186EUR$4,750USD£3,677GBP
- Report
- April 2023
- 90 Pages
South Korea
From €4186EUR$4,750USD£3,677GBP
- Report
- April 2023
- 90 Pages
France
From €4186EUR$4,750USD£3,677GBP
- Report
- April 2023
- 70 Pages
Canada
From €4186EUR$4,750USD£3,677GBP
- Report
- April 2023
- 75 Pages
Japan
From €4186EUR$4,750USD£3,677GBP
- Report
- April 2023
- 70 Pages
Mexico
From €4186EUR$4,750USD£3,677GBP
- Report
- April 2023
- 71 Pages
South Africa
From €4186EUR$4,750USD£3,677GBP
- Report
- March 2018
- 112 Pages
Global
From €3745EUR$4,250USD£3,290GBP
- Report
- January 2024
- 150 Pages
Global
From €3393EUR$3,850USD£2,980GBP
€4274EUR$4,850USD£3,754GBP
- Report
- June 2025
- 74 Pages
From €3040EUR$3,450USD£2,670GBP
- Report
- February 2023
- 50 Pages
China
From €2644EUR$3,000USD£2,322GBP
- Report
- January 2024
- 103 Pages
Global
From €3500EUR$4,255USD£3,182GBP

The Artificial Kidney market is a subset of the larger Biomaterials market. It is composed of products and services that are used to replace or supplement the functions of a natural kidney. These products and services include dialysis machines, artificial kidneys, and other related medical devices. Artificial kidneys are typically made from biocompatible materials such as polymers, ceramics, and metals. These materials are designed to mimic the natural kidney's ability to filter and remove waste from the body.
The Artificial Kidney market is driven by the increasing prevalence of kidney diseases, as well as the need for more efficient and cost-effective treatments. Additionally, advances in technology have enabled the development of more sophisticated artificial kidneys, which can provide better patient outcomes.
Some of the major companies in the Artificial Kidney market include Baxter International, Fresenius Medical Care, NxStage Medical, Asahi Kasei, and Medtronic. Show Less Read more